• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

The Trader Daily: Volatility Cuts Both Ways

Trying to exploit the PRGO-VRX dealings could leave you with a losing hand.
By BOB BYRNE Apr 26, 2016 | 07:00 AM EDT
Stocks quotes in this article: PRGO, VRX

There's always something moving in the market, even when the indices appear to be stuck in the mud. On Monday we saw shares of Perrigo (PRGO) implode on an earnings warning and confirmation that the company's CEO was resigning to take the top spot at Valeant Pharmaceuticals (VRX).

These sorts of announcements tend to attract day time-frame traders looking for volatility to exploit. And provided you were either quick with a long position in PRGO off the open, or confident with a short position in either PRGO or VRX after the opening buyers ran out of energy, you likely finished with a profit.

As always, however, volatility cuts both ways. Anyone failing to remain unemotional and detached from the situation could easily have finished the session holding an ugly losing position -- a position they intended to enter, and exit within a matter of minutes or hours.

As far as the E-Mini S&P 500 futures (Es) are concerned, roughly 1 million contracts changed hands over a regular-session range of 12.5 handles. While there's no denying the session's range and volume were quite a bit smaller than usual, patient traders should have been able to identify at least a couple of tradable setups.

Given our recent discussion on the volume weighted average price (VWAP), I thought I'd share a 15-minute chart with a potential buy setup from Monday's auction.

15-Minute Intraday S&P 500 Futures Volume Profile
Esignal
View Chart » View in New Window »

As you can see on the chart above, the Es broke beneath Friday's low early in the session Monday. As discussed in Monday's Trader Daily, the opening rejection of 2080.25 to 2081.25 (#1 on the chart above) and break beneath Friday's intraday low (#2 on the chart above) provided sellers with an opportunity to test the low 1970s. Unfortunately for bears, that test was quickly rejected and price failed to gain acceptance.

The immediate rejection from the low 2070s resulted in a quick probe of the session's VWAP and Friday's intraday lows (#3 on the chart above), but as is often the case with any initial test of a breakdown zone and VWAP, price is once again rejected. The bulls managed to push through VWAP and back into Friday's intraday range shortly after 1 p.m. ET, and as you can see in the area highlighted in green (#4 on the chart above), the pullback to the breakout area, which conveniently lined up with Friday's intraday low and the session's VWAP, provided scalpers with an opportunity to get long.

Suffice it to say such opportunities aren't always this clean. But the general logic behind trading against VWAP, especially when it lines up with other short-term reference points, should not be overlooked.

Moving on to Tuesday's Es auction, we'll look to begin the session with a focus on 2078.50 to 2080. As long as value remains above that six-tick area, our baseline expectation will be for an upside test of 2088 and 2093.25.

10-Minute Intraday S&P 500 Futures Volume Profile
Investor R/T
View Chart » View in New Window »

Monday's afternoon rally resulted in the Es closing above the low 2080s. And while the rally may have occurred on relatively low volume, it left the contract above the eight-day exponential moving average nonetheless. No matter how much one dislikes the current market, this does leave dip buyers in the driver's seat.

A failed trade from 2078.50 to 2080 traps Monday's late-day buyer and encourages day time-frame sellers to auction the contract back down through 2074.75, and on toward 2069.75. Those expecting the contract to trade back up toward 2100 in the short term do not want to see a value shift beneath 2069.75, as such a move would suggest bearish continuation toward 2058.50/2060 (and potentially 2025) is right around the corner.

Any trading or volume profile related questions can be posted in the comments section below, emailed to me at parkcityyeti@gmail.com or posted to my Twitter feed @ByrneRWS

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Byrne had no positions in the stocks mentioned.

TAGS: Investing | U.S. Equity | Healthcare

More from Healthcare

Boston Scientific Could Be Wicked Good in This Kind of Market

Brad Ginesin
May 24, 2022 2:13 PM EDT

Here's why this healthcare stock is a potential port in the storm for investors.

2 Biotech Stocks to Own as M&A Potentially Gathers Steam

Bret Jensen
May 11, 2022 11:35 AM EDT

I like these names as stand-alone entities but they should also attract interest from larger players.

China Faces 'Tsunami' of Covid Infection That Could Swamp the System

Alex Frew McMillan
May 11, 2022 9:00 AM EDT

A new study suggests 1.55 million people could die if China abandons zero-Covid, with the intensive-care system needing 15.6 times existing capacity.

I'm Giving Dynavax Another Shot -- a Booster Shot

Bret Jensen
May 8, 2022 7:31 AM EDT

Despite an earnings miss, DVAX show promise in several vaccine fronts and I'm doubling down on the name.

In This Environment, I'd Be More Risk Averse With Intuitive Surgical

Stephen Guilfoyle
Apr 25, 2022 10:50 AM EDT

The firm has been hurt and continues to be hurt by the effects of the pandemic.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:24 PM EDT PAUL PRICE

    An Interesting Chart

    I'm betting heavily that stocks will be way up aga...
  • 10:10 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "Market Timing for Dummies"
  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login